• Toll Free: +1- 844-445-2861
  •   sales@futuregenicreports.com

Pharmaceuticals

 
Global Coronary Atherectomy Devices Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

"Atherectomy is defined as minimally invasive surgery for removal of plaque blockages from coronary.

Scope of the Report:
This report focuses on the Coronary Atherectomy Devices in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Boston Scientific
Philips
Cardiovascular Systems

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Laser Atherectomy
Orbital Atherectomy
Rotational Atherectomy
Others

Market Segment by Applications, can be divided into
Hospitals
Clinics
Ambulatory Surgery Centers

Published

Read more
Global Allergy Immunotherapy Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

"Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

Scope of the Report:
This report focuses on the Allergy Immunotherapy in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
WOLW Pharma
Holister Stier
Leti

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Subcutaneous Immunotherapy
Sublingual Immunotherapy

Market Segment by Applications, can be divided into
Allergic Rhinitis
Allergic Asthma
Other

Published

Read more
Global Advanced Wound Care Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

"This report studies the Advanced Wound Care market, Advanced wound care products are designed to treat more complex wounds and—in order to be covered under insurance—usually require a doctor’s order. This includes hydrogels, hydrocolloids, alginates, and film and foam dressings. Advanced wound care treatments revolve around the principle of moisture therapy, which provides moisture to the wound site to encourage natural cell repair while giving the wound room to breathe. Products utilized in moist wound care generally fit better around different wound shapes and sizes and are more resistant to environmental inhibitors and foreign particles.

Scope of the Report:
This report focuses on the Advanced Wound Care in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Acelity
Smith & Nephew
Molnlycke
ConvaTec
Coloplast
Organogenesis
Integra Lifesciences Corporation
Medline Industries
3M
Hollister Incorporated
Human Biosciences
Medtronic
Hartmann Group
B.Braun Melsungen
BSN Medical
Urgo Medical
Mimedx Group, Inc.
Nitto Denko
Winner Medical Group

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Advanced Wound Dressings
Bioactives
Devices

Market Segment by Applications, can be divided into
Acute wounds
Chronic Wounds
Surgical Wounds

Published

Read more
Global Pimozide Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

"Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.

Scope of the Report:
This report focuses on the Pimozide in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
1Mg
2Mg
4Mg

Market Segment by Applications, can be divided into
Hospitals
Drugstores
Others

Published

Read more
Global Orthopedic Braces & Support Casting & Splints Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

"Orthopedic braces are medical devices designed to address musculoskeletal issues; they are used to properly align, correct the position, support, stabilize, and protect certain parts of the body (particularly the muscles, joints, and bones) as they heal from injury or trauma. These medical devices are often prescribed for the patient to wear during the process of recovery and rehabilitation.

Scope of the Report:
This report focuses on the Orthopedic Braces & Support Casting & Splints in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
DJO Global
Ottobock
Ossur
3M Company
Bauerfeind
DeRoyal
Medi GmbH & Co.
Zimmer
Lohmann & Rauscher
Breg
THUASNE
ORTEC
BSN Medical
Tynor Orthotics
DUK-IN
Prime Medical
Adhenor
Aspen
Rcai
Truelife
Huici Medical
Dynamic Techno Medicals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Braces & Support
Casting Supplies
Splinting Supplies

Market Segment by Applications, can be divided into
Hospitals
Retail Pharmacies
Online Sales

Published

Read more
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Infrared Heaters Market 2018 Forecast to 2023

"An infrared heater is a body with a higher temperature which transfers energy to a body with a lower temperature through electromagnetic radiation. Depending on the temperature of the emitting body, the wavelength of the peak of the infrared radiation ranges from 780 nm to 1 mm. No contact or medium between the two bodies is needed for the energy transfer. Infrared heaters can be operated in vacuum or atmosphere.

Scope of the Report:
This report focuses on the Infrared Heaters in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Jarden Consumer Solutions
Twin-Star
Edenpure
Schwank
Tansun
Honeywell
IR Energy
Dr Infrared Heater
Lifesmart
Midea
Infralia
Airmate
Solamagic
FRICO
Thermablaster
Singfun
Gree

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Near Infrared Heaters
Medium Infrared Heaters
Far Infrared Heaters

Market Segment by Applications, can be divided into
Outdoor
Indoor
 

Published

Read more
Global Anti-decubitus Cushions Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

This report focuses on the Anti-decubitus Cushions in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Varilite
Permobil
Ottobock
Invacare
Sunrise Medical
Winncare Group
Action Products
Yuwell
Drive DeVilbiss
Trulife
Supracor
Young Won Medical
Star Cushion
SPM
Aquila Corporation

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Air Cushions
Gel Cushions
Foam Cushions
Others

Market Segment by Applications, can be divided into
Hospitals
Recuperation Institutions
Home

Published

Read more
Global Patient Lateral Transfer Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

"Performing lateral patient transfers is a common task in the daily tasks of healthcare workers. Although somewhat routine and performed in high quantities, transferring patients from one surface to another can become complicated and cause potential injuries to the staff and the patient.

Scope of the Report:
This report focuses on the Patient Lateral Transfer in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Stryker
Arjo
Handicare
Hill-Rom
Joerns Healthcare
Medline
Sizewise
Airpal
Air-Matt
Cantel Medical
EZ Way
Hovertech
PPS
Wy’East Medical

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Air Assisted Transfer Device
Slide Sheets

Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgical Centers
Others

Published

Read more
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Ursodeoxycholic Acid Market 2018 Forecast to 2023

"""Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear.

Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.""

Scope of the Report:
This report focuses on the Ursodeoxycholic Acid in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
ICE
Mitsubishi Tanabe Pharma
Daewoong Chemical
PharmaZell GmbH
Zhangshanbelling
Dipharma Francis
Grindeks
Erregierre
Abil Chempharma
Biotavia Labs
Suzhou Tianlu
Arcelor Chemicals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Synthetic UDCA
Extraction UDCA

Market Segment by Applications, can be divided into
Pharmacy
Health Products

Published

Read more
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Foam Dressing Market 2018 Forecast to 2023

"A Foam Dressing, consists of sterile polyurethane foam, hydrocolloid adhesive (polystyrene, sodium carboxymethyl cellulose, etc.), which is an opaque polyurethane dressing that is permeable to vapors but partially occlusive to liquids. It is typically used to cover wounds over bony ridges or near inflamed skin, especially in burns, open wounds, pressure ulcers,venous ulcers, diabetic, etc.

Scope of the Report:
This report focuses on the Foam Dressing in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Smith & Nephew
M?lnlycke Health Care
Coloplast Corp
3M
ConvaTec
Acelity
Medline Industries, Inc
Cardinal Health
B.Braun
Medtronic
Hollister Incorporated
Paul Hartmann
Top-medical
Lohmann & Rauscher
Winner Medical Group
Derma Sciences

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Adhesive Foam Dressing
Non-Adhesive Foam Dressing

Market Segment by Applications, can be divided into
Acute Wounds
Postoperative Wounds
Chronic Wounds

Published

Read more
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Duchenne Muscular Dystrophy Market 2018 Forecast to 2023

"Duchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.

Scope of the Report:
This report focuses on the Duchenne Muscular Dystrophy in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
PTC Therapeutics
Sarepta Therapeutics
Bristol-Myers Squibb
ITALFARMACO
BioMarin
Daiichi Sankyo
Solid Biosciences
Summit Therapeutics
FibroGen
NS Pharma
Pfizer
ReveraGen BioPharma
Wave Life
Genethon
Santhera Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Deflazacort
Prednisone
Others

Market Segment by Applications, can be divided into
Male
Female

Published

Read more
Global Ubiquinone Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

"This report studies the Ubiquinone market, Coenzyme Q10, also known as ubiquinone, ubidecarenone, coenzyme Q, and abbreviated at times to CoQ10, is a naturally-occurring compound located in every cell in the body. Coenzyme Q10, or merely CoQ10, plays a key role in producing energy in the mitochondria, the part of a cell responsible for the production of energy in the form of ATP. Coenzyme Q10, in some cases referred to merely as CoQ10, is synthesized inside our bodies, it is also known to be found in meats, particularly in the heart, such as pork, chicken and beef, and many oils.

Scope of the Report:
This report focuses on the Ubiquinone in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Kingdomway
Kaneka
ZMC
Space Biology
NHU
Pharma Essentia
Yuxi Jiankun
Haotian

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Chemical Synthesis
Microbial Fermentation
Others

Market Segment by Applications, can be divided into
Food
Medicine
Cosmetics
Others
 

Published

Read more
Global Indirect Restorative Materials of Dental Consumables Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"Indirect tooth restoration involves customized tooth replacements in the form of crowns, onlays, or inlays. A crown covers the entire chewing surface of a tooth, an inlay lies within the cusps of the tooth, and an onlay covers and one or more cusp tip, including part of the chewing surface. An indirect tooth restoration will require more than one office visit because the inlay or onlay must be fabricated in a lab. Crowns, inlays and onlays can be made from a variety of materials. Gold is still used for some inlays, but for someone concerned about white teeth, porcelain and tooth-colored composite resins are other options.

Scope of the Report:
This report focuses on the Indirect Restorative Materials of Dental Consumables in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
3M ESPE
Dentsply Sirona
Danaher
GC Corporation
Ivoclar Vivadent
Shofu
Mitsui Chemicals (Heraeus Kulzer)
VOCO GmbH
Ultradent
Coltene
DMG

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
All-Ceramic
Porcelain Fused to Metal
Cast-Gold Alloys

Market Segment by Applications, can be divided into
Hospital
Dental

Published

Read more
Global Human Coagulation Factor VIII Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A.

Scope of the Report:
This report focuses on the Human Coagulation Factor VIII in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Shire (Baxter)
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Recombinant Factor VIII
Plasma-derived Factor VIII

Market Segment by Applications, can be divided into
Hemophilia A
Spontanous / Trauma
Spontanous / Trauma
Other

Published

Read more
Global Epinephrine Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Scope of the Report:
This report focuses on the Epinephrine in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Mylan Inc
Sanofi SA
Impax
ALK Abello
Lincoln Medical Ltd
AMPHASTAR

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Others

Market Segment by Applications, can be divided into
Anaphylaxis
Others

Published

Read more
Global All Vaccine Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Scope of the Report:
This report focuses on the All Vaccine in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
CNBG
ChengDa Bio
Changsheng Life
Zhifei
SINOVAC BIOTECH
NuoCheng Bio
Hualan Bio
Kangtai
SANOFI PASTEUR S.A.
Novartis
GSK

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, tetanus
Pneumococcal
Other

Market Segment by Applications, can be divided into
For Adult
For Child

Published

Read more
Global Botox Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species in the reproduction process. Botox is a polypeptide which molecular weight is 150kD and is also one of the most poisonous natural proteins. It is so easy to be produced, purified and refined due to its stable property that Botox is used widely in Experimental Research and Clinical Application at the early stage.

Scope of the Report:
This report focuses on the Botox in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Allergan
Ipsen
Merz Pharmaceuticals
Medytox
US World Meds
LIBP

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
50U
100U
Others

Market Segment by Applications, can be divided into
Medical
Cosmetic

Published

Read more
Global Active Pharmaceutical Ingredients Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"This report studies the Active Pharmaceutical Ingredients market. An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.

Scope of the Report:
This report focuses on the Active Pharmaceutical Ingredients in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Synthetic APIs
Biotech APIs

Market Segment by Applications, can be divided into
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others

Published

Read more
Global Cytokines Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"""Cytokines are a large group of small signaling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well. Their use in disease diagnosis and treatment has proven very beneficial over the past number of years as their use as biomarkers has been adopted as a means to understanding disease and therapies. They have expanded into more disease relevant, specialized panels for a more accurate assessment of various diseases that include cardiovascular disease, asthma, inflammation, cancer, diabetes, and rheumatoid arthritis.
""
Scope of the Report:
This report focuses on the Cytokines in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
AbbVie
Johnson & Johnson
GlaxoSmithKline
Novartis
Roche
Pfizer
Sanofi
Bayer HealthCare Pharmaceuticals
Thermo Fisher Scientific
Biocon
Biotechne

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
TNF
IL
IFN
EGF
Others

Market Segment by Applications, can be divided into
Cancer and Malignancy
Asthma / Airway Inflammation
Arthritis
Others

Published

Read more
Global Monoclonal Mouse Antibody Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Kohler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.

Scope of the Report:
This report focuses on the Monoclonal Mouse Antibody in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
IgM
IgG
IgA
Other

Market Segment by Applications, can be divided into
Therapeutic
Research
Diagnostic

There are 15 Chapters to deeply display the global Monoclonal Mouse Antibody market.

Chapter 1, to describe Monoclonal Mouse Antibody Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Monoclonal Mouse Antibody, with sales, revenue, and price of Monoclonal Mouse Antibody, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Monoclonal Mouse Antibody, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Monoclonal Mouse Antibody market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Monoclonal Mouse Antibody sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source"

Published

Read more
Global Gene Synthesis Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.

Scope of the Report:
This report focuses on the Gene Synthesis in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Genescript
GeneArt (Thermofischer)
IDT
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Market Segment by Applications, can be divided into
Commercial
Academic Research

There are 15 Chapters to deeply display the global Gene Synthesis market.

Chapter 1, to describe Gene Synthesis Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Gene Synthesis, with sales, revenue, and price of Gene Synthesis, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Gene Synthesis, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Gene Synthesis market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Gene Synthesis sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source"

Published

Read more
United States Pediatric Vaccine Market 2017 – Demand, Insights, Analysis, Opportunities Segmentation and Forecast to 2024

"United States Pediatric Vaccine market is likely to reach nearly US$ 10 Billion by 2024.

Growth in US pediatric vaccine market can be attributed to factors such as increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccine development.

The research report titled “United States Pediatric Vaccine Market 2017 – Demand, Insights, Analysis, Opportunities Segmentation and Forecast to 2024” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the United States pediatric vaccine market.

The report contains a granular analysis of the market segmentation, reveal facts on the market size, volume and revenues and provides forecasts through 2024. The report also provides a deep and thorough evaluation of the top 10 pediatric vaccines by disease indication. On the basis of disease indication, the top 10 pediatric vaccines provide an in-depth analysis of doses administered, number of children being vaccinated and market size. The report also explores detailed description of growth drivers and inhibitors of the United States pediatric vaccine market.

The report concludes with the profiles of major players in the United States pediatric vaccine market. The key market players are evaluated on various parameters such as company overview, pediatric vaccine portfolios and latest development & trends of the pediatric vaccine market.


Major Pediatric Vaccines (Disease Indication) Covered Under This Report Are:

Diphtheria, Tetanus & Pertussis (DTap)
Hepatitis A
Varicella/Chicken Pox
Pneumococcal
Haemophilus Influenzae Type B (HIB)
Polio
Rotavirus
Hepatitis B
Influenza Pediatric
Measles, Mumps & Rubella (MMR)


Key Companies Covered in the Report are as follows:

Sanofi Pasteur
GlaxoSmithKline(GSK)
Merck & Co.
Pfizer Inc
Grifols

Key Deliverables in the Study

Market Definition for the specified topic along with identification of key drivers and inhibitors for the market
It provides a growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed based on how the market is predicted to grow
It helps in understanding the key product segments and their future
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
A comprehensive list of key market players along with the analysis of their current pediatric vaccines portfolios and latest development and trends.
"

Published

Read more
Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024

"United States flu vaccine market is expected to reach nearly US$ 3 Billion by 2024. Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine.

Long–term Growth Projection and Development:

• Sanofi to Acquire Protein Sciences Corporation
• It is likely that more than 185 Million persons being vaccinated with flu vaccines in 2024.
• Nearly 160 Million doses of flu vaccines have shipped to US for the 2017-2018 flu season
• It is projected that GSK flu vaccine sales value will reach around US$ 1.5 Billion by 2024
• BiondVax reports positive phase 2b clinical trial results for its universal flu vaccine

“Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024” provides a deep and thorough evaluation of the United States flu vaccine market. The report provides an in–depth analysis of the flu vaccination pattern in both Children and Adults in the United States. It also provides essential insights into flu vaccine production, price, consumption, supply, distribution, demand and specification. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and promising flu vaccines in the clinical development. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.

The report concludes with the profiles of major players in the US flu vaccine market such as Sanofi Pasteur, GSK and Seqirus. The major market players are evaluated on various parameters such as company overview, product outlook, latest development & trends and sales analysis of flu vaccine market from 2011 to 2022. The report also entails major drivers and inhibitors in the US flu vaccine market.

Key Topics Covered in the Report

• Market Overview: United States Flu Vaccine Market (2010 - 2024)
• United States Number of Persons Vaccinated with Flu Vaccine (2010 - 2024)
• United States Flu Vaccine Production, Price, Consumption, Supply, Distribution, Demand and Specification
• Reimbursement & Regulatory System in the US Flu Vaccine Market
• Mergers, Acquisitions, Key Agreements & Collaborations
• Promising Flu Vaccine in Clinical Development
• Flu Vaccine Clinical Trial Insights by Phase, Company & Country
• Key Drivers and Inhibitors of the US Flu Vaccine Market
• Key Companies Analysis

Major Flu Vaccines Covered Under This Report Are:


• Fluzone High–Dose
• Fluzone Quadrivalent
• Intradermal (ID) Trivalent
• Vaxigrip
• Fluarix Quadrivalent
• Flulaval Quadrivalent
• Flucelvax Quadrivalent
• Afluria Quadrivalent
• Agrippal
• Fluad
• Fluvirin
• Fluvax

Key Companies Covered in This Report:

• Seqirus
• Sanofi Pasteur
• GlaxoSmithKline(GSK)
"

Published

Read more
Epilepsy Drugs Market: Global Demand, Growth Potential & Opportunity Outlook 2021

"Epilepsy Drugs Market is likely to reach nearly USD 5.5 Billion by the year end of 2021.

Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasing healthcare costs as part of government austerity measures, particularly in Europe and low accessibility to antiepileptic drugs in low and middle income countries, are likely to restrict the market growth.

Vimpat is the undisputed leading drug of Global Epilepsy Drugs Market. It has a market share of nearly 22% in 2016 and is expected that Vimpat will gain its momentum till the forecasting period. Keppra was the second highest market share taker with more than 19% share in 2016 but the prospect of this drug will change due to the patent expiration in 2018 and its share decline to XX% by 2021. It is expected that Lamictal will be second leading drug with nearly XX% share by 2021. Onfi hold the third highest share of the Epilepsy Drugs market, being followed by Depakine by the year end of 2021.

The research report titled “Epilepsy Drugs Market: Global Demand, Growth Potential & Opportunity Outlook 2021” examines the market, competitive landscape and trends of the Global Epilepsy Drug Market. This report analyzes market data and provides a better understanding of Epilepsy Drugs sales value and demand in the Global Market. Market outlook in value terms for the forecasted period for Epilepsy Drugs Market has been detailed in the report. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the Global Epilpesy Drugs Market.

The report concludes with the profiles of major players in the Epilepsy Drugs Market such as UCB, EISAI, Pfizer, Sanofi and Lundbeck. The major market players are evaluated on various parameters such as company overview and latest development and trends in the Epilepsy Drugs Market


Key Topics Covered in the Report

• Worldwide Epilepsy Drugs Market Analysis (2013 – 2021)
• Worldwide Epilepsy Drugs Market Share (2013 – 2021)
• Worldwide Epilepsy Drugs Brand Market Performance (2013 – 2021)
• Epilepsy Drugs Market – Major Deal Types
• Key Companies Analysis
• Key Drivers and Inhibitors of the Epilepsy Drugs Market

Key Epilepsy Drugs Covered in the Report are as follows:

1. Vimpat(Lacosamide)
2. Keppra(Levetiracetam)
3. Briviact(Brivaracetam)
4. Lamictal(Lamotrigine)
5. Neurontin (Gabapentin)
6. Depakine (Sodium Valproate)
7. Sabril (Vigabatrin)
8. Onfi(Clobazam)
9. Fycompa(Perampanel)
10. Inovelon/Banzel(Rufinamide)
11. Zonegran (Zonisamide)
12. Zebinix (Eslicarbazepine Acetate)

Key Companies Covered in the Report are as follows:

1. UCB
2. EISAI
3. Pfizer
4. Sanofi
5. Lundbeck
"

Published

Read more
Influenza Vaccines Market in Top 5 European Countries to 2022 - Market Size, Development and Forecasts

"Influenza Vaccine Market is expected to reach more than US$ 1 Billion across the 5 major markets (5MM) of the France, Germany, Italy, Spain and United Kingdom by the year end of 2022.

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against Influenza, introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most countries.

United Kingdom influenza vaccine market is the most attractive of those covered in the report. The United Kingdom market for influenza vaccine is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. Germany will be the second–largest market for influenza vaccine which is expected to grow at a CAGR of XX% by 2022. France is expected to be third largest influenza vaccine market being followed by Italy by the end of the forecasted period.

Further, prudent analysis has been done on the competitor’s part, where three major players grab major share of the influenza vaccine market by revenue. Sanofi Pasteur, GlaxoSmithKline(GSK), Seqirus, AstraZeneca and Protein Sciences Corporation are the key influencers with their products in the influenza vaccine market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projection using a suitable set of assumptions and methodologies. It provides essential insights into influenza vaccine sales forecast for the top five countries, comprising the UK, France, Italy, Spain and Germany until 2022. It also covers vaccination patterns and geographic distribution and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials, pipeline and promising vaccines in influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details. The report concludes with the profiles of major players

in the influenza vaccine market, such as Sanofi Pasteur, GSK, Sequirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of influenza vaccine market from 2011 to 2022. The report also entails major drivers and barriers of influenza vaccine market.

Five Major European Markets(5MM) covered in the report are as follows:

1. United Kingdom
2. France
3. Italy
4. Spain
5. Germany

Major and Promising Vaccines covered in the report are as follows:

1. Fluzone High–Dose
2. Fluzone Quadrivalent
3. Intradermal (ID) Trivalent
4. Vaxigrip
5. Fluarix Quadrivalent
6. Flulaval Quadrivalent
7. Fluenz Tetra
8. FluMist Quadrivalent
9. Flublok
10. VN–100
11. M–001
12. VAX–2012Q
13. TAK – 850
14. Flucelvax Quadrivalent
15. Afluria Quadrivalent
16. Agrippal
17. Fluad
18. Fluvirin
19. Fluvax

Key Companies Covered in the Report are as follows:

1. Sanofi Pasteur
2. GlaxoSmithKline(GSK)
3. Seqirus
4. AstraZenecca
5. Protein Sciences Corporation
6. Novavax
7. Daiichi–Sankyo
8. Mitsubishi Tanabe Pharma
9. BiondVax Pharmaceuticals Ltd
10. VaxInnate

"

Published

Read more
Zika Virus Vaccines by Company Profile, Deals Type, Funding, Clinical Trials Insight, Regulatory Landscape & Recent Development

"It is predicted that Zika virus vaccines shot will available to the public by 2018.

Zika virus is an emerging viral disease that is transmitted through the bite of an infected mosquito, primarily Aedes aegypti, the same vector that transmits chikungunya, dengue and yellow fever. Zika has a similar epidemiology, clinical presentation and transmission cycle in urban environments as chikungunya and dengue, although it generally causes milder illness.

The highest risk is to pregnant women due to the connection the virus has with serious birth defects. Pregnant women who contract the virus have a high possibility of giving birth to a baby with microcephaly, a neurodevelopment disorder, where a baby is born with an unusually small head due to abnormal brain development in the womb or after birth. Complications of this disorder include seizures and developmental issues.

Due to the serious nature of global risk, the WHO has declared the microcephaly cases associated with the Zika virus a Public Health Emergency of International Concern (PHEIC). With no vaccines or cure the virus and its risks are expected to continue to spread. The WHO is predicting up to 4 Million Zika cases in the Americas by 2016 and the World Bank is projecting the short-term economic impact for 2016, in Latin America and the Caribbean to be about US$3.5 Billion.

With fears of Zika virus reaching new heights, Zika virus vaccines are gaining popularity. Many Government agencies and research institutes support pharmaceutical companies for the development & manufacturing of Zika virus vaccines. It is predicted that Zika virus vaccines shot will available to the public by 2018.

The research report presents a comprehensive study of the Zika virus vaccines with details. It provides essential insights of introduction of Zika virus, current situation and areas with Zika virus and funding in Zika virus vaccines research. Additionally, the report includes assessment of clinical trials and regulatory landscape of Zika virus vaccines development. Key trends in terms of partnerships, collaborations and licensing agreements are analyzed with details.

The report concludes with the profiles of major players in the Zika virus vaccines development such as Sanofi Pasteur, ImmunoVaccines Inc, Inovio Pharmaceuticals, Inc, Valneva, Bharat Biotech International Pvt. Ltd., NewLink Genetics. The major players are evaluated on various parameters such as company overview, product outlook and Zika virus vaccines latest development and trends.

This 87 Page report has been analyzed from 7 viewpoints:

1. Zika Virus – Introduction, Signs and Symptoms, Transmission, Diagnosis, Treatment & Prevention
2. Current Situation & Areas with Zika Virus
3. Competitive Landscape of The Zika Virus Vaccines Companies
4. Funding in Zika Virus Vaccines Research
5. Zika Virus Vaccines – Clinical Trials Insight by Phase & Trial Status
6. Zika Virus Vaccines – Regulatory Landscape
7. Key Companies Analysis
"

Published

Read more
United States Influenza Vaccine Market, Vaccination Analysis, Distribution, Production, Pipeline Insights, Clinical Trials, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast,2016 to 2022

"United States Influenza Vaccine Market is expected to reach more than US$ 2.5 Billion by the year end of 2022.

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccine and introduction of quadrivalent influenza vaccine.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It provides essential insights into United States influenza vaccine market and forecast. It covers vaccination pattern, doses distribution, production and offers a clear view of the regulatory landscape. Additionally, the report includes insight of clinical trials, pipeline and promising vaccines in United States influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.

The report concludes with the profiles of major players in the influenza vaccine market such as Sanofi Pasteur, GSK, Seqirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of influenza vaccine market from 2011 to 2022. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period. The report also entails major drivers and barriers of influenza vaccine market.

Major and Promising Vaccine covered in the report are as follows:

1. Fluzone High–Dose
2. Fluzone Quadrivalent
3. Intradermal (ID) Trivalent
4. Vaxigrip
5. Fluarix Quadrivalent
6. Flulaval Quadrivalent
7. Fluenz Tetra
8. FluMist Quadrivalent
9. Flublok
10. VN–100
11. M–001
12. VAX–2012Q
13. TAK – 850
14. Flucelvax Quadrivalent
15. Afluria Quadrivalent
16. Agrippal
17. Fluad
18. Fluvirin
19. Fluvax

Key Companies Covered in the Report are as follows

1. Sanofi Pasteur
2. GlaxoSmithKline(GSK)
3. Seqirus
4. AstraZenecca
5. Protein Sciences Corporation
6. Novavax
7. Daiichi–Sankyo
8. Mitsubishi Tanabe Pharma
9. BiondVax Pharmaceuticals Ltd
10. VaxInnate
"

Published

Read more
Seasonal Influenza Vaccine Market Size, Country Outlook, Vaccination Analysis, Pipeline Insights, Clinical Trials Statement, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast,2016 to 2022

"Seasonal Influenza Vaccine Market is expected to reach more than US$ 4 Billion across the seven major markets (7MM) of the United States, France, Germany, Italy, Spain, United Kingdom and Japan by the year end of 2022.

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against seasonal influenza, introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most countries. The barriers limiting the growth of the influenza market include limited patient awareness regarding the threat of influenza and the importance of influenza vaccinations, high investment and strict regulations act as barriers for new entrants.

The United States seasonal influenza vaccine market is the most attractive of those covered in the report. The United States market for seasonal influenza vaccine is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. United Kingdom will be the second–largest market for seasonal influenza vaccine which is expected to grow at a CAGR of XX% by 2022. Germany is expected to be third largest seasonal influenza vaccine market being followed by Japan by the end of the forecasted period.

Further, prudent analysis has been done on the competitor’s part, where three major players grab major share of the seasonal influenza vaccine market by revenue. Sanofi Pasteur, GlaxoSmithKline(GSK), Seqirus, AstraZeneca and Protein Sciences Corporation are the key influencers with their products in the seasonal influenza vaccine market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projection using a suitable set of assumptions and methodologies. It provides essential insights into seasonal influenza vaccine sales forecasts for the top seven countries, comprising the US, the UK, France, Italy, Spain, Germany and Japan until 2022. It also covers vaccination patterns and geographic distribution and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials, pipeline and promising vaccines in seasonal influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details. The report concludes with the profiles of major players in the seasonal influenza vaccine market such as Sanofi Pasteur, GSK, Sequirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook, and sales analysis of seasonal influenza vaccine market from 2011 to 2022. The report also entails major drivers and barriers of seasonal influenza vaccine market.

Seven Major Markets(7MM) covered in the report are as follows:


1. United States
2. United Kingdom
3. France
4. Italy
5. Spain
6. Germany
7. Japan


Major and Promising Vaccines covered in the report are as follows:


1. Fluzone High–Dose
2. Fluzone Quadrivalent
3. Intradermal (ID) Trivalent
4. Vaxigrip
5. Fluarix Quadrivalent
6. Flulaval Quadrivalent
7. Fluenz Tetra
8. FluMist Quadrivalent
9. Flublok
10. VN–100
11. M–001
12. VAX–2012Q
13. TAK – 850
14. Flucelvax Quadrivalent
15. Afluria Quadrivalent
16. Agrippal
17. Fluad
18. Fluvirin
19. Fluvax

Seasonal Influenza Vaccine Report is segmented with 10 Chapters:

Chapter 1: Chapter one is the introduction with Executive Summary

Chapter 2: Chapter two provides overall recent and forecasts data for the seasonal influenza vaccine market in the top seven countries. This Chapter divided into 4 parts

1. Overall seasonal influenza vaccine market data from 2010 to 2022
2. Overall number of persons vaccinated with seasonal influenza vaccine data from 2010 to 2022
3. Seasonal influenza vaccine market share in the top seven countries data from 2010 to 2022
4. Persons being vaccinated with influenza vaccine share in the top seven countries data from 2010 to 2022

Chapter 3: Key market drivers and barriers in the seasonal influenza vaccine market.

Chapter 4: Chapter four gives detailed recent and forecasts for the seasonal influenza vaccine markets in the US, the UK, France, Italy, Spain, Germany and Japan, comprising of market size, total number of persons vaccinated, number of children vaccinated, number of 60+ years of age persons vaccinated, number of pregnant women vaccinated, number of chronic medical condition persons vaccinated, number of healthcare workers vaccinated and vaccination coverage.

Chapter 5: Chapter five gives detailed information on seasonal influenza vaccine production & distribution in United States. The information includes vaccine choices remain available for patients, providers, prices of a dose of vaccine, production, supply, and allocation by the major seasonal influenza vaccine manufacturers, seasonal influenza vaccine distribution & demand, seasonal influenza vaccine effectiveness, managing influenza with diagnostic resources, distribution method of seasonal influenza vaccination.


Chapter 6: Chapter six offers information about regulatory landscape including the approval process and an overview of the regulatory authorities in the United States, EU and Japan.

Chapter 7: Chapter seven highlights key M&A deals that took place in the seasonal influenza vaccine market between 2003 and 2015 and lists the major collaborations, licensing, exclusive and distribution agreements deals.

Chapter 8: Chapter eight provides detailed pipeline influenza vaccines in various companies’ pipelines with clinical development and early stage development vaccines.

Chapter 9: Chapter nine offers detailed information of the recruiting clinical trials statement by phase, trial status, study sponsor name and study phase.

Chapter 10: Chapter ten gives information on the key players in the market with business overview, product outlook and sales analysis of the seasonal influenza vaccine.

"

Published

Read more
Kidney Transplant Market by Country (United States, Germany, France, Italy, United Kingdom, Japan, Argentina, Mexico, Spain, Brazil) Analysis and Forecast to 2021

Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease (ESRD) patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the number of organ donors is increasing, an increase in transplant procedures is bound to happen. However, due to costlier procedure the market shift is expected to occur in Asian countries where medical tourism is being promoted.

Kidney Transplant Performed Analysis: United States is the leading kidney transplant performed with more than 40% share in 2015. The number of Kidney transplant done in 10 countries covered in the report was more than 40 Thousand in 2015. Brazil is the second leading kidney transplant performed country with more than 10% share. United Kingdom stands at the 3rd position in kidney transplant number. France and Mexico stand at the 4th and 5th place respectively in 2015.

Kidney Transplant Market Analysis: United States is the leading market for kidney transplant in 10 countries covered being followed by France. Spain stands at the 3rd position followed by Germany. Japan and Italy are competing very closely with each other to capture the maximum market share.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides the number of kidney transplant, as well as market and market shares of Kidney Transplant market. The report entails major organ transplant (immunosuppressant) drug sales analysis. This report also covers key development, drivers and challenges of Kidney Transplant market.

The 10 countries covered in the report are analysed from two viewpoints:

1. Number of Kidney Transplant Performed (2008 - 2021)
2. Kidney Transplant Market (2008 - 2021)


Based on geographical distribution, the Kidney Transplant market is categorized into following sub-markets:

1. United States
2. Germany
3. France
4. Italy
5. United Kingdom
6. Japan
7. Argentina
8. Mexico
9. Spain
10. Brazil

Organ Transplantation Immunosuppressive/Rejection Drugs Analysis in the report are as follows

1. Cellcept (Mycophenolate Mofetil)
2. Prograf(Tacrolimus)
3. Rapamune (Sirolimus)
4. Myfortic (Mycophenolic Acid)
5. Neoral / Sandimmune (Cyclosporine)
6. Zortress / Certican (Everolimus)

 

Published

Read more
Global Cell and Tissue Culture Supplies Sales Market Report 2025

In this report, the global Cell and Tissue Culture Supplies market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Cell and Tissue Culture Supplies for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Cell and Tissue Culture Supplies market competition by top manufacturers/players, with Cell and Tissue Culture Supplies sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Stemcell Technologies
Wheaton Industries
GE Healthcare
Thermo Fisher Scientific
VWR International
Merck KGaA
Lonza Group
Corning
Promocell GmbH
Eppendorf AG

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Consumable Products
Instruments

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Vaccine Production
Biopharmaceutical Production
Toxicity Testing
Gene Therapy
Drug Screening & Development
Cancer Research
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Published

Read more
Global Cancer Antibody Drug Conjugates Sales Market Report 2018

In this report, the global Cancer Antibody Drug Conjugates market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Cancer Antibody Drug Conjugates for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Cancer Antibody Drug Conjugates market competition by top manufacturers/players, with Cancer Antibody Drug Conjugates sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Novartis
Merck
Roche
AbbVie
UCB
Bristol-Myers Squibb
Stem CentRx
Biogen Idec
Nordic Nanovector
Millennium
Biotest AG
PDL BioPharma
Progenics Pharmaceuticals
Seattle Genetics
Viventia Biotechnologies
AbGenomics Corporation
Helix BioPharma
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
First & Second Generation ADCs
Third Generation ADCs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Clinics
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Published

Read more
Glutathione Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025

This report studies the Glutathione market status and outlook of global, from angles of players, regions, product types and end industries; this report analyzes the top players in global market, and splits the Glutathione market by product type and application/end industries.

The global Glutathione market was XX million US$ in 2017 and is expected to XX million US$ by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Glutathione in these regions, from 2013 to 2025 (forecast), covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia and Vietnam))
South America (Brazil etc.)
Middle East and Africa (North Africa and GCC Countries)

The major companies in this report including
Kyowa Hakko Bio
Shandong Jincheng Biological Pharmaceutical
KOHJIN Life Sciences
Shenzhen GSH Bio-tech
Kaiping Genuine Biochemical Pharmaceutical

By the product type, the market is primarily split into
Glutathione Reduced
Glutathione Oxidized

By the end users/application, this report covers the following segments
Pharmaceuticals
Health Products
Cosmetics
Food
Other

Published

Read more
Antiviral Drugs Market Global Size, Status and Forecast 2025

This report studies the global Antiviral Drugs market, analyzes and researches the Antiviral Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
AbbVie
Bristol-Myers Squibb Company
Cipla
F. Hoffmann-La Roche
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
Mylan
Teva Pharmaceutical Industries

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, the product can be split into
Branded Drugs
Generic Drugs

Market segment by Application, Antiviral Drugs can be split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Published

Read more
Cosmetic Implant Market Global Research Report 2025

In this report, the global Cosmetic Implant market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cosmetic Implant in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

Global Cosmetic Implant market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Aesthetic and Reconstructive Technologies (AART) Inc.
3M Health Care
DENTSPLY International Inc.
Allergan, Inc.
GC Aesthetics
Implantech Associates Inc.
Mentor Worldwide LLC
Institut Straumann AG
Sientra Inc.
Nobel Biocare Holding AG
Zimmer Holdings Inc
Spectrum Designs Medical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Polymers
Ceramics
Metals
Biological Material

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Dental Implants
Breast Implants
Facial Implants
Penile Implants
Buttock Implants
Calf Implants

If you have any special requirements, please let us know and we will offer you the report as you want.

Published

Read more

SORT BY PRICE







REPORT TYPE

  • USA Office

    244 , Madison Avenue
    New York City, NY - 10016
    United States


    UK Office

    109 ,Straford Street,Leeds
    West Yorkshrie LS11 6JG
    United Kingdom

Copyright © 2018-19 futuregenicreports.com. All rights reserved.